Zydus Lifesciences has signed an agreement to amend certain clauses of the joint venture agreement (JVA) with Bayer (South East Asia) PTE, one of the companies of the Bayer group. An agreement to amend certain clauses of the JVA to enable participation in tenders of some government institutions / public sector undertakings for some products through an affiliate entity of a JV Partner.
Earlier, the company had entered into an JVA with Bayer (South East Asia) PTE dated January 28, 2011 and pursuant to which the JV Partners formed a joint venture company i.e. Bayer Zydus Pharma.
Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: